Navigation Links
The Advisory Board Company Schedules Fourth Quarter Conference Call for May 5, 2009
Date:4/24/2009

WASHINGTON, April 24 /PRNewswire-FirstCall/ -- The Advisory Board Company (Nasdaq: ABCO) announced today that it will hold a conference call hosted by Robert W. Musslewhite, Chief Executive Officer and Director, and Michael T. Kirshbaum, Chief Financial Officer, to discuss the Company's financial results for the quarter ended March 31, 2009. The call will be held on Tuesday, May 5, 2009, at 6:00 p.m. Eastern Time. The Company plans to release its fourth quarter financial results after the market closes on Tuesday, May 5, 2009.

The conference call will be available via live web cast on the Company's web site at www.advisoryboardcompany.com in the section titled "The Firm," found under the tab "Investor Relations." To participate by telephone, the dial-in number is 866.713.8307 and the access code is 44493092. Call participants are advised to dial in at least five minutes prior to the call to register. The web cast will be archived for seven days: from 8:00 p.m., Tuesday, May 5, 2009, until 8:00 p.m., Eastern Time, Tuesday, May 12, 2009.

About The Advisory Board Company

The Advisory Board Company provides best practices research, analysis, executive education and leadership development, decision support tools and installation support services primarily to the health care industry, focusing on business strategy, operations and general management issues. The Company provides best practices and research through discrete programs to a membership of more than 2,700 organizations, including leading hospitals, health systems, pharmaceutical and biotech companies, health care insurers, medical device companies, universities and other education institutions. Members of each program are typically charged a fixed annual fee and have access to an integrate set of services that may include best practice research studies, executive education seminars, customized research briefs, decision support tools, and web-based access to the program's content database.

www.advisoryboardcompany.com


'/>"/>
SOURCE The Advisory Board Company
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Trius Appoints Don Batts and Ralph Corey to Clinical Advisory Board
2. NexBio Completes Clinical Advisory Board for the Advanced Development of DAS181 (Fludase(R)*), a First-In-Class Medicine for Influenza
3. Stemedica Signs Scientific Advisory Board Agreement with Leading Pediatric Burn & Wound Care Researcher
4. Paul Keim Appointed to febits Scientific Advisory Board
5. Otonomy Introduces Scientific Advisory Board
6. Novexel Strengthens its Scientific Advisory Board With the Appointment of Dr. Karen Bush
7. Catalyst Biosciences Expands Scientific Advisory Board With Leading Experts in Protease Therapeutic Discovery and Development
8. Joseph Loscalzo, M.D., PhD. to Join N30 Pharma Board and Chair Scientific Advisory Board
9. Leading Advisory Firm, PROXY Governance, Recommends Avigen Shareholders Vote on GOLD Card to Remove Incumbent Directors and Elect BVFs Stockholder-Oriented Nominees
10. Micromet Adds Sir Walter Bodmer and Bernard Fox to Its Advisory Panel for BiTE Antibody Therapeutics
11. Advanced Life Sciences Receives Notice of Planned Cethromycin Review by FDA Advisory Committee
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... Rolf ... join the faculty of the University of North Carolina Kenan-Flagler Business School ... and entrepreneurship at UNC Kenan-Flagler, with a focus on the school’s international efforts, ...
(Date:6/24/2016)... , June 24, 2016  Regular discussions on a ... take place between the two entities said Poloz. ... Ottawa , he pointed to the country,s ... the federal government. ... said, "Both institutions have common economic goals, why not sit ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Researchers at the ... commonly-identified miRNAs in people with peritoneal or pleural mesothelioma. Their findings are the subject ... it now. , Diagnostic biomarkers are signposts in the blood, lung fluid or ...
(Date:6/23/2016)... Mass. , June 23, 2016   ... development of novel compounds designed to target cancer ... napabucasin, has been granted Orphan Drug Designation from ... the treatment of gastric cancer, including gastroesophageal junction ... stemness inhibitor designed to inhibit cancer stemness pathways ...
Breaking Biology Technology:
(Date:4/28/2016)... , April 28, 2016 First quarter ... (139.9), up 966% compared with the first quarter of 2015 ... totaled SEK 589.1 M (loss: 18.8) and the operating margin was ... (loss: 0.32) Cash flow from operations was SEK 249.9 ... 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. The ...
(Date:4/15/2016)... April 15, 2016  A new partnership announced ... accurate underwriting decisions in a fraction of the ... priced and high-value life insurance policies to consumers ... With Force Diagnostics, rapid testing (A1C, Cotinine ... readings (blood pressure, weight, pulse, BMI, and activity ...
(Date:3/31/2016)... 2016   LegacyXChange, ... "Company") LegacyXChange is excited to release its ... to be launched online site for trading 100% guaranteed ... will also provide potential shareholders a sense of the ... an industry that is notorious for fraud. The video ...
Breaking Biology News(10 mins):